If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynairgen Regulatory News (SNG)

  • There is currently no data for SNG

Total Voting Rights

31 Oct 2008 09:00

RNS Number : 9595G
Synairgen plc
31 October 2008
 



31 October 2008

Synairgen plc (the "Company")

Total Voting Rights

In accordance with DTR 5.6.1 of the FSA's Disclosure Rules and Transparency Rules (DTR), the total issued share capital of the Company with voting rights is 22,392,308 ordinary shares of 1p each ("Ordinary Shares"). The Company does not hold any Ordinary Shares in Treasury.

The above figure of 22,392,308 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FSA's Disclosure and Transparency Rules.

For further information:

Synairgen plc

John Ward

+44 (0)2380 512800

Teathers Limited

Shaun Dobson/Claes Spang

+44 (0)20 7426 9000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVRFKCKQQBDDCKB
Date   Source Headline
7th Sep 20203:53 pmRNSHolding(s) in Company
3rd Sep 20205:58 pmRNSHolding(s) in Company
1st Sep 20204:41 pmRNSSecond Price Monitoring Extn
1st Sep 20204:36 pmRNSPrice Monitoring Extension
24th Aug 20204:41 pmRNSSecond Price Monitoring Extn
24th Aug 20204:36 pmRNSPrice Monitoring Extension
21st Aug 20205:28 pmRNSHolding(s) in Company
13th Aug 20204:41 pmRNSSecond Price Monitoring Extn
13th Aug 20204:35 pmRNSPrice Monitoring Extension
13th Aug 20207:57 amRNSHolding(s) in Company
10th Aug 20209:50 amRNSHolding(s) in Company
7th Aug 20208:22 amRNSHolding(s) in Company
5th Aug 20205:51 pmRNSHolding(s) in Company
31st Jul 20208:37 amRNSHolding(s) in Company
29th Jul 20204:43 pmRNSHolding(s) in Company
28th Jul 20203:13 pmRNSHolding(s) in Company
28th Jul 20209:01 amRNSHolding(s) in Company
27th Jul 20209:06 amRNSSecond Price Monitoring Extn
27th Jul 20209:00 amRNSPrice Monitoring Extension
23rd Jul 20204:40 pmRNSSecond Price Monitoring Extn
23rd Jul 20204:36 pmRNSPrice Monitoring Extension
22nd Jul 20202:05 pmRNSHolding(s) in Company
21st Jul 20204:15 pmRNSHolding(s) in Company
21st Jul 20207:00 amRNSHolding(s) in Company
21st Jul 20207:00 amRNSClarification Regarding COVID-19 Trial
20th Jul 20204:40 pmRNSSecond Price Monitoring Extn
20th Jul 20204:35 pmRNSPrice Monitoring Extension
20th Jul 202011:05 amRNSSecond Price Monitoring Extn
20th Jul 202011:00 amRNSPrice Monitoring Extension
20th Jul 20209:05 amRNSSecond Price Monitoring Extn
20th Jul 20209:00 amRNSPrice Monitoring Extension
20th Jul 20207:00 amRNSPositive results from trial in COVID-19 patients
15th Jul 20208:00 amRNSHolding(s) in Company
3rd Jul 202012:43 pmRNSHolding(s) in Company
3rd Jul 202012:38 pmRNSHolding(s) in Company
29th Jun 20203:18 pmRNSResult of AGM
22nd Jun 20204:41 pmRNSSecond Price Monitoring Extn
22nd Jun 20204:36 pmRNSPrice Monitoring Extension
19th Jun 20207:00 amRNSGrant of Options
18th Jun 20207:00 amRNSNational expansion of home-based COVID-19 trial
17th Jun 20204:40 pmRNSSecond Price Monitoring Extn
17th Jun 20204:36 pmRNSPrice Monitoring Extension
12th Jun 20202:01 pmRNSPrice Monitoring Extension
10th Jun 20205:32 pmRNSHoldings in Company
10th Jun 20205:27 pmRNSHoldings in Company
10th Jun 202010:46 amRNSHolding(s) in Company
3rd Jun 20204:21 pmRNSAnnual Report and Notice of Annual General Meeting
28th May 20207:00 amRNSRecruitment of Patients in SG016 Trial Completed
26th May 20207:00 amRNSInitiation of SNG001 in home setting
26th May 20207:00 amRNSPreliminary results for the year ended 31 Dec 2019

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.